Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)
China · Delayed Price · Currency is CNY 9.72
-0.17 (-1.72%)
Aug 24, 2026, 3:04 PM CST
Jiangxi Sanxin Medtec Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,073 | 4,484 | 3,835 | 3,965 | 3,425 | 4,977 | |
Market Cap Growth | -3.85% | 16.93% | -3.26% | 15.74% | -31.17% | 7.76% |
Enterprise Value | 4,867 | 4,352 | 3,790 | 3,905 | 3,297 | 4,926 |
Last Close Price | 9.72 | 8.54 | 7.05 | 6.95 | 5.95 | 8.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.84 | 16.93 | 16.86 | 19.19 | 18.55 | 31.92 |
Forward PE | - | 112.28 | 112.28 | 112.28 | 112.28 | 112.28 |
PS Ratio | 2.96 | 2.73 | 2.56 | 3.05 | 2.56 | 4.27 |
PB Ratio | 3.24 | 2.89 | 2.72 | 2.97 | 2.97 | 5.08 |
P/TBV Ratio | 3.95 | 3.62 | 3.43 | 3.77 | 3.81 | 6.69 |
P/FCF Ratio | 25.96 | 20.50 | 22.29 | 75.75 | 17.88 | 32.13 |
P/OCF Ratio | 11.88 | 9.74 | 9.84 | 11.67 | 8.52 | 15.09 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.84 | 2.65 | 2.53 | 3.00 | 2.47 | 4.23 |
EV/EBITDA Ratio | 10.81 | 10.51 | 10.75 | 13.25 | 12.35 | 20.31 |
EV/EBIT Ratio | 15.01 | 14.75 | 14.40 | 17.59 | 16.17 | 26.34 |
EV/FCF Ratio | 24.91 | 19.90 | 22.03 | 74.61 | 17.20 | 31.80 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.14 | 0.15 | 0.17 | 0.15 | 0.11 | 0.04 |
Debt / EBITDA Ratio | 0.50 | 0.55 | 0.67 | 0.69 | 0.48 | 0.17 |
Debt / FCF Ratio | 1.22 | 1.05 | 1.38 | 3.88 | 0.67 | 0.27 |
Net Debt / Equity Ratio | -0.20 | -0.25 | -0.20 | -0.13 | -0.20 | -0.21 |
Net Debt / EBITDA Ratio | -0.74 | -0.94 | -0.80 | -0.58 | -0.87 | -0.86 |
Net Debt / FCF Ratio | -1.79 | -1.79 | -1.65 | -3.25 | -1.21 | -1.35 |
Asset Turnover | 0.72 | 0.71 | 0.71 | 0.68 | 0.84 | 0.88 |
Inventory Turnover | 4.94 | 5.34 | 4.92 | 4.29 | 5.07 | 5.13 |
Quick Ratio | 1.16 | 1.16 | 1.06 | 0.85 | 0.86 | 0.94 |
Current Ratio | 1.63 | 1.52 | 1.43 | 1.22 | 1.30 | 1.45 |
Return on Equity (ROE) | 19.81% | 19.60% | 18.06% | 17.94% | 18.66% | 18.84% |
Return on Assets (ROA) | 8.45% | 7.93% | 7.74% | 7.27% | 7.98% | 8.82% |
Return on Invested Capital (ROIC) | 22.87% | 23.11% | 20.64% | 18.78% | 21.25% | 21.63% |
Return on Capital Employed (ROCE) | 16.80% | 16.20% | 16.00% | 15.10% | 16.20% | 18.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 5.56% | 5.91% | 5.93% | 5.21% | 5.39% | 3.13% |
FCF Yield | 3.85% | 4.88% | 4.49% | 1.32% | 5.59% | 3.11% |
Dividend Yield | 3.04% | 3.52% | 4.25% | 1.66% | 1.94% | 1.34% |
Payout Ratio | 58.21% | 61.63% | 58.04% | 30.97% | 38.68% | 34.62% |
Buyback Yield / Dilution | 0.02% | -0.36% | 0.53% | -0.71% | -0.35% | 0.53% |
Total Shareholder Return | 3.05% | 3.15% | 4.79% | 0.95% | 1.58% | 1.88% |